期刊文献+

糖尿病大鼠阴茎海绵体组织中SK3表达的研究 被引量:2

Diabetes mellitus reduces the expression of SK3 in rat cavernous tissues
下载PDF
导出
摘要 目的:SK3是小电导型钙依赖钾通道之一,是内皮依赖性超极化因子(endothelium-derived hyperpolar-izing factor,EDHF)通路中关键物质,本研究探讨糖尿病对大鼠阴茎海绵体小电导钙激活性钾通道蛋白SK3表达的影响。方法:雄性SD大鼠60只,其中50只大鼠采用腹腔注射链脲佐菌素(streptozocin,STZ)制作糖尿病模型组(DM),注射STZ未能成模大鼠用作STZ药物对照组(STZ),其余10只大鼠用于空白对照组。造模成功后饲养8周,注射阿朴吗啡(apomorphine,APO)80μg/kg后,观察大鼠阴茎勃起情况;随后采用RT-PCR、Western印迹技术检测SK3mRNA和蛋白在大鼠阴茎海绵体中的表达水平。结果:DM组(26只)有14只大鼠阴茎勃起,勃起率为54%,STZ组(15只)和空白对照组(10只)勃起率均为100%。DM组SK3mRNA表达(0.50±0.09)显著低于STZ组(1.15±0.03)和空白对照组(1.21±0.04)(P<0.05)。DM组SK3蛋白表达(0.65±0.06)与STZ组(1.28±0.04)和空白对照组(1.34±0.05)相比存在显著差异(P<0.05)。STZ组和空白对照组之间大鼠阴茎勃起情况和SK3mRNA及蛋白表达无差异(P>0.05)。结论:糖尿病可明显降低大鼠阴茎勃起功能,且这可能与大鼠阴茎海绵体SK3表达减少密切相关。 Objective:SK3,one of the small conductance calcium-activated potassium channels,is the key substance of the endothelium-derived hyperpolarizing factor(EDHF)passway.This study aimed to investigate the expression of SK3 in the cavernous tissue of rats with diabetes mellitus(DM).Methods:Twenty-six DM models were made by injection of streptozocin(STZ)out of 50 male Sprague-Dawley rats,and another 15 that failed to be modeled were included in an STZ group.Ten healthy male rats were taken as blank controls.Eight weeks later,the penile erectile function of the rats was detected by injection of apomorphine(APO)at 80 μg/kg,and the expression of SK3 in the cavernous tissue was determined by RT-PCR and Western blot.Results:Penile erection was observed in 14(54%)of the 26 DM rat models and in all the rats of the STZ and blank control groups.Both the mRNA and protein expressions of SK3 were significantly lower in the DM(0.50 ± 0.09 and 0.65 ± 0.06)than in the STZ(1.15 ± 0.03 and 1.28 ± 0.04)and blank control groups(1.21 ± 0.04 and 1.34 ± 0.05)(P 0.05).There were no significant differences between the STZ and blank control groups in either penile erection or mRNA and protein expressions of SK3(P 0.05).Conclusion:Diabetes mellitus can significantly reduce erectile function in rats,which may be related to the decreased expression of SK3 in the corpus cavernosum.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2010年第3期236-239,共4页 National Journal of Andrology
关键词 糖尿病 勃起功能障碍 阴茎海绵体 小电导钙激活性钾通道 diabetes mellitus erectile dysfuntion corpus cavernosum small conductance calcium-activated potassium channel
  • 相关文献

参考文献9

  • 1Angulo J, Cuevas P, Femandez A, et al. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun, 2003, 312(4) : 1202-1208.
  • 2李三祥,戴玉田.糖尿病性勃起功能障碍大鼠血管紧张素Ⅱ及其受体变化的研究[J].中华男科学杂志,2005,11(5):346-349. 被引量:5
  • 3许松,高建平.糖尿病性勃起功能障碍的发病机制及治疗进展[J].中华男科学杂志,2004,10(3):218-221. 被引量:43
  • 4Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res, 2002, 14 (6) : 466-471.
  • 5Kun A, Kiraly I, Pataricza J, et al. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries. J Sex Med, 2008, 5(5) : 1114-1125.
  • 6Kohler R, Hoyer J. The endothelium-derived hyperpolarizing factor: Insights from genetic animal models. Kidney Int, 2007, 72 (2) : 145-150.
  • 7Chen MX, Gorman SA, Benson B, et al. Small and intermediate conductance Ca^2 + -activated K^ + channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavemosum. Naunyn Schmiedebergs Arch Pharmacol, 2004, 369(6): 602-615.
  • 8Hilgers RH, Webb RC. Reduced expression Of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol, 2007, 292 ( 5 ) : H2275-2284.
  • 9Zhou Z, Jiang D J, Jia S J, et al. Down-regulation of endogenous nitric oxide synthase inhibitors on endothelial SK3 expression. Vascul Pharmacol, 2007, 47(5-6) : 265-271,.

二级参考文献41

  • 1陈修 陈维洲 等.心血管药理学[M].北京:人民卫生出版社,1997.324-325.
  • 2Jackson G. Sexual dysfunction and diabetes [ J ]. Int J Clin Pract,2004, 58(4) :358-362.
  • 3Dorrance AM, Lewis RW, Mills TM. Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats[J]. Int J Impot Res, 2002, 14(6) :494-497.
  • 4Johnston CI. Biochemistry and pharmacology of the renin-angiotensin system[ J]. Drugs, 1990, 39(Suppl 1 ) :21-31.
  • 5Heaton JP, Varrin SJ, Morales A. The characterization of a bioassay of erectile function in a rat model[J]. J Urol, 1991, 145(5) :1099-1102.
  • 6Parving HH. Angiotensin-converting enzyme inhib ition in diabetes: above and beyond the beneficial effect of blood pressure [ J] ?Curr Hypertens Res, 2004, 6 (5) :366-368.
  • 7Maas R, Schwedhelm E, Albsmeier, et al. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function [ J ]. Vasc Med, 2002, 7 ( 3 ) :213-225.
  • 8Becker AJ, Uckert S, Stief CG, et al. Possible role of bradykinin and angiotensin Ⅱ in the regulation of penile erection and detumenescence [ J ]. Urology, 2001,57 ( 1 ): 193-198.
  • 9Dzau VJ. Vascular renin-angiotensin system and vascular protection [ J ]. J Cardiovasc Pharmacol, 1993, 22 ( Suppl 5 ) :S1 -S9.
  • 10Akingba AG, Burnett AL. Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat[J]. Mol Urol, 2001, 5(4):189-197.

共引文献46

同被引文献26

  • 1Fusco F, Razzoli E, hnbimbo C, et al. A new era in the treatment of erectile dysfunction : chronic phosphodiesterase type 5 inhibition [J].BJU Int,2010, 105 ( 12 ) : 1634 - 1639.
  • 2Leo CH, Hart JL, Woodman OL. Impairment of both nitric oxide- mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes [ J ]. Br J Pharma- col,2011,162(2) :365 -377.
  • 3Gonzalez-Corrochano R, La Fuente J, Cuevas P, et al. Ca^2+ -activa- ted K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in hmnan penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction [ J ]. Br J Pharmacol,2013,169 ( 2 ) :449 - 461.
  • 4Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 rag and 10 mg in the treatment of erectile dysfunction : Results of amulticenter, randonized,double-blind,placebo controlled trial[ J]. Eur Urol,2006,50 (2) :351 -359.
  • 5Lee JW, Park HJ,Park NC. Serum high-sensitivity C-reactive pro- rein levels and response to 5 mg tadalafil Once daily in patients with erectile dysfunction and diabetes[ J ]. Korean J Urol,2013,54 (12) :858 -864.
  • 6Lee CH,Kim HS, Coo M J, et al. Chronic administration of udena- fil,a selective phosphodiesterase type 5 inhibitor,promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury [ J ]. J Sex Med,2011, 8 ( 5 ) : 1330 - 1340.
  • 7MALAVIGE LS,LEVY JC.Erectile dysfunction in diabetes mellitus[J].J Sex Med,2009,6:232-247.
  • 8MOSTAFA T,ASHED L A,OTB K.estosterone and chronicsildenafil / tadalafil anti-apoptotic role in aged diabetic rats [J].Int J Impot Res,2010,22(4): 255-261.
  • 9BEHR-ROUSSEL D,GORNY D,MEVEL K,et al.Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis [J].Eur Urol,2005,47(1): 87-91.
  • 10FUSCO F,RAZZOLI E,IMBIMBO C,et al.A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition [J].BJU Int,2010,105(12): 1634-1639.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部